Organotropic metastasis in colorectal cancer: integrating molecular pathways with therapeutic opportunities.
Colorectal cancer (CRC), characterized by high incidence and mortality rates, is an aggressive malignancy that significantly burdens public health.
APA
Jing H, Gao Y, et al. (2025). Organotropic metastasis in colorectal cancer: integrating molecular pathways with therapeutic opportunities.. Frontiers in immunology, 16, 1686071. https://doi.org/10.3389/fimmu.2025.1686071
MLA
Jing H, et al.. "Organotropic metastasis in colorectal cancer: integrating molecular pathways with therapeutic opportunities.." Frontiers in immunology, vol. 16, 2025, pp. 1686071.
PMID
41409281
Abstract
Colorectal cancer (CRC), characterized by high incidence and mortality rates, is an aggressive malignancy that significantly burdens public health. Metastasis represents the principal factor contributing to treatment failure in CRC patients, largely due to limited comprehension of the underlying mechanisms governing this phenomenon. CRC metastasis involves multiple factors, including dynamics within the tumor microenvironment (TME), epithelial-mesenchymal transition (EMT), and the dissemination of cancer cells through the circulatory and lymphatic systems. These mechanisms are regulated by complex molecular interactions. A deeper understanding of the metastatic processes and the identification of viable therapeutic targets could substantially advance innovative clinical interventions. This review highlights key contributors to CRC metastasis, integrates relevant molecular mechanisms with distinct patterns of organ-specific spread, and emphasizes the latest advancements in this field. Additionally, it explores experimental models of CRC and metastasis, provides mechanistic insights, and addresses challenges in the clinical management of metastatic CRC. This article aims to facilitate future research and highlight promising therapeutic opportunities for clinical translation.
MeSH Terms
Humans; Colorectal Neoplasms; Tumor Microenvironment; Epithelial-Mesenchymal Transition; Animals; Neoplasm Metastasis; Signal Transduction
같은 제1저자의 인용 많은 논문 (2)
- Retraction notice to "Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p" [Biomed. Pharmacother. 110 (2019), 825-833].
- Active monitoring vs. spontaneous reporting of antineoplastic drug-related adverse drug reactions: evidence from the Chinese hospital pharmacovigilance system.